Leap Investments »

BioCryst Pharmaceuticals shares owned by Leap Investments

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Leap Investments from 13F filings

Historical chart of Leap Investments investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Leap Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Leap Investments

Quarter filed Position value Share count Share price at filing
2020-06-30 $311k 65k 4.77

More positions owned by Leap Investments

Penn National Gaming Common Stock (PENN)
Crowdstrike Holdings Common Stock (CRWD)
Domino's Pizza Common Stock (DPZ)
Phillips 66 Common Stock (PSX)
Seattle Genetics Common Stock
Discover Financial Services Common Stock (DFS)
Uber Technologies Common Stock (UBER)
Advanced Micro Devices Common Stock (AMD)
Annaly Capital Management Reit
Coca-Cola Co/The Common Stock (KO)
Taiwan Semiconductor Manufacturing Depositary Receipt (TSM)
Western Digital Corp Common Stock (WDC)
Raytheon Technologies Corp Common Stock (RTX)
Ford Motor Common Stock (F)
DexCom Common Stock (DXCM)

View all positions for Leap Investments

Top funds holding BioCryst Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Kynam Capital Management
Deerfield Management Company
Geode Capital Management
RP Management
Rock Springs Capital Management
Jennifer Ranahan
Braidwell
Fisher Investments
Nuveen Asset Management
Two Sigma Advisers
Ameriprise Financial

View all funds holding BioCryst Pharmaceuticals